Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C78861
http://purl.obolibrary.org/obo/NCIT_C78861
|
|---|---|
| Preferred Name | Allogeneic Melanoma Vaccine AGI-101H |
| Definitions |
A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells. |
|---|---|
| prefLabel | Allogeneic Melanoma Vaccine AGI-101H
|
| label | Allogeneic Melanoma Vaccine AGI-101H
|
| NCI_META_CUI | CL387596
|
| PDQ_Closed_Trial_Search_ID | 601981
|
| code | C78861
|
| prefixIRI | NCIT:C78861
|
| in_subset | |
| Preferred_Name | Allogeneic Melanoma Vaccine AGI-101H
|
| Maps_To | Allogeneic Melanoma Vaccine AGI-101H
|
| NCI_Drug_Dictionary_ID | 601981
|
| Legacy Concept Name | Allogeneic_Melanoma_Vaccine_AGI-101H
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 601981
|
| Semantic_Type |
Pharmacologic Substance
Immunologic Factor
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |